Nasdaq · Healthcare
MiniMed Group, Inc. (MMED)
As-reported financials and recent SEC filings for MiniMed Group, Inc., latest fiscal period FY2026. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.10B
Net income
$-333.0M
Net margin
-10.7%
Diluted EPS
$-1.30
ROE
-9.2%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2026 | FY2026 | FY2026 |
|---|---|---|---|
| Revenue | $3.10B | $2.71B | $2.47B |
| Gross profit | $1.68B | $1.53B | $1.44B |
| Operating income | $-190.0M | $-146.0M | $-69.0M |
| Net income | $-333.0M | $-213.0M | $-112.0M |
| Diluted EPS | $-1.30 | $-0.84 | $-0.44 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
32026-07-06
View on EDGAR →32026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →42026-07-06
View on EDGAR →Largest Healthcare peers
Go deeper on MMED
Search MiniMed Group, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.